Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dice Therapeutics Inc
(NQ:
DICE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dice Therapeutics Inc
< Previous
1
2
3
Next >
What 9 Analyst Ratings Have To Say About DICE Therapeutics
August 09, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Crash In Q3
August 07, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Eli Lilly To Report Q2 Earnings: What's In The Cards?
August 05, 2023
Eli Lilly & Company will report second-quarter 2023 results on Aug. 8, before the market opens.
Via
Talk Markets
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
July 17, 2023
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for...
Via
Benzinga
Why Shares of Ventyx Biosciences Rose Monday
July 03, 2023
The company has several promising autoimmune therapies.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
June 26, 2023
Via
Benzinga
Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review
June 23, 2023
But the major indexes and leading stocks generally showed healthy action.
Via
Investor's Business Daily
Why Dice Therapeutics Stock Bolted Higher This Week
June 22, 2023
The small-cap drugmaker fetched a hefty premium in a buyout deal with Eli Lilly.
Via
The Motley Fool
Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?
June 21, 2023
The pharma giant's latest acquisition might be on the small side, but it could yield an important new growth driver in the years ahead.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023
June 21, 2023
Via
Benzinga
Analyst Expectations for DICE Therapeutics's Future
June 20, 2023
Via
Benzinga
Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics
June 20, 2023
Via
Benzinga
Why DICE Therapeutics Stock Is Soaring Tuesday
June 20, 2023
DICE TherapeuticsInc (NASDAQ: DICE) shares are trading higher Tuesday afterEli Lilly And Co (NYSE: LLY) agreed to acquire ...
Via
Benzinga
2 Biopharma Stocks Making Big Moves Tuesday
June 20, 2023
Markets looked poised for a pause, but these stocks didn't stand still.
Via
The Motley Fool
Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know
June 20, 2023
Lilly could get a couple of promising autoimmune-disease drugs with the transaction.
Via
The Motley Fool
Crude Oil Down 2%; Dragonfly Energy Shares Plunge
June 20, 2023
U.S. stocks traded lower toward the end of trading, with Dow Jones dropping over 150 points on Tuesday. The Dow traded down 0.50% to 34,129.29while the NASDAQ fell 0.16% to 13,668.76 The S&P 500, also...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 20, 2023
Via
Benzinga
Dow Dips Over 300 Points; DICE Therapeutics Shares Spike Higher
June 20, 2023
U.S. stocks traded lower midway through trading, with Dow Jones dropping over 300 points on Tuesday. The Dow traded down 0.96% to 33,969.42 while the NASDAQ fell 0.74% to 13,588.13. The S&P 500, also...
Via
Benzinga
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday
June 20, 2023
The company received a buyout offer from Eli Lilly.
Via
The Motley Fool
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 20, 2023
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740.
Via
Benzinga
PLTR Stock Alert: Why Raymond James Just Downgraded Palantir
June 20, 2023
Palantir (PLTR) stock is on the move Tuesday after Raymond James analysts downgraded the company's shares but increased its price target.
Via
InvestorPlace
DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday
June 20, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
RIVN Stock Alert: Rivian Jumps on the Tesla Bandwagon for EV Charging
June 20, 2023
Rivian (RIVN) stock is in the news Tuesday as investors react to the electric vehicle (EV) company joining Tesla's (TSLA) charging standard.
Via
InvestorPlace
US Stocks Mixed; Housing Starts Surge In May
June 20, 2023
U.S. stocks traded mixed this morning, with Dow Jones dropping over 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.52% to 34,120.19 while the NASDAQ rose 0.15% to...
Via
Benzinga
Eli Lilly To Acquire Small Company DICE Therapeutics Focused On Autoimmune Diseases For $2B
June 20, 2023
Eli Lilly And Co (NYSE: LLY) has agreed to acquire DICE Therapeutics Inc (NASDAQ: DICE), a biopharmaceutical company that leverages its proprietary DELSCAPE technology platform to develop oral...
Via
Benzinga
Why Is Dice Therapeutics (DICE) Stock Up 38% Today?
June 20, 2023
Dice Therapeutics (DICE) stock is surging higher on Tuesday after Eli Lilly (LLY) announced plans to acquire the biopharmaceutical company.
Via
InvestorPlace
Dice Therapeutics Stock Catapults To Record High On $2.4 Billion Eli Lilly Buyout
June 20, 2023
Eli Lilly is adding a new suite of experimental immunology treatments to its pipeline.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 20, 2023
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
May 24, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
May 22, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.